Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis ; volume:5 ; number:1 ; day:15 ; month:11 ; year:2012 ; pages:1-9 ; date:12.2012
Journal of ovarian research ; 5, Heft 1 (15.11.2012), 1-9, 12.2012
- Creator
-
Lane, Denis
Matte, Isabelle
Rancourt, Claudine
Piché, Alain
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1757-2215-5-34
- URN
-
urn:nbn:de:101:1-2021081506273422817717
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lane, Denis
- Matte, Isabelle
- Rancourt, Claudine
- Piché, Alain
- SpringerLink (Online service)
Other Objects (12)
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL-induced apoptosis : between tumor therapy and immunopathology
Bortezomib-mediated sensitization for TRAIL-induced apoptosis in glioblastoma
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Individual-based modeling of TRAIL-induced apoptosis in cancer cell populations
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
Regulation function of acid sphingomyelinase (ASM) and ceramide in TRAIL-induced apoptosis
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL-induced apoptosis : between tumor therapy and immunopathology
Bortezomib-mediated sensitization for TRAIL-induced apoptosis in glioblastoma
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Individual-based modeling of TRAIL-induced apoptosis in cancer cell populations
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
Regulation function of acid sphingomyelinase (ASM) and ceramide in TRAIL-induced apoptosis
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL-induced apoptosis : between tumor therapy and immunopathology
Bortezomib-mediated sensitization for TRAIL-induced apoptosis in glioblastoma
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Individual-based modeling of TRAIL-induced apoptosis in cancer cell populations
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma